Release date: 2009-04-08 Recently, a groundbreaking development in cardiac care has been announced by American researchers. A new type of implantable cardiac defibrillator has shown remarkable success in preventing sudden cardiac death among stroke patients. Sudden cardiac arrest remains the leading cause of death in the United States, surpassing lung cancer, breast cancer, and even AIDS in annual fatalities. This life-saving device is now being recognized as a critical tool in reducing mortality rates. Recent studies have demonstrated that patients who receive this implant experience a significant reduction in their risk of death—up to 50% lower than those without it. The device functions similarly to a pacemaker, designed to monitor and regulate heart rhythm. It works by detecting abnormal electrical activity in the heart, which often occurs after a heart attack or due to left ventricular damage. When a dangerous arrhythmia is detected, the defibrillator delivers an electrical pulse to restore normal heart function. This mechanism can be crucial in preventing fatal outcomes, especially in high-risk individuals. Despite its potential, experts caution that only a small percentage of patients currently benefit from this technology. Less than 20% of eligible individuals are receiving the implant, according to recent data. Therefore, doctors recommend that patients with a ventricular ejection fraction (EF) below 40% should consult with their healthcare providers to determine if this preventive treatment is appropriate for them. As awareness grows, so does the hope that more lives will be saved through early intervention and advanced medical technology. Shanghai Medical Device Industry Association Endocrine System,Torso Mannequin Model,Anatomical Liver Model,Human Torso Anatomy Model Yinchuan Erxin Technology Co., LTD , https://www.exmedmodel.com